Endothelial Progenitor Cells Promote Directional Three-Dimensional Endothelial Network Formation by Secreting Vascular Endothelial Growth Factor Citation

Endothelial progenitor cell (EPC) transplantation induces the formation of new blood-vessel networks to supply nutrients and oxygen, and is feasible for the treatment of ischemia and cardiovascular diseases. However, the role of EPCs as a source of proangiogenic cytokines and consequent generators of an extracellular growth factor microenvironment in three-dimensional (3D) microvessel formation is not fully understood. We focused on the contribution of EPCs as a source of proangiogenic cytokines on 3D microvessel formation using an in vitro 3D network model. To create a 3D network model, EPCs isolated from rat bone marrow were sandwiched with double layers of collagen gel. Endothelial cells (ECs) were then cultured on top of the upper collagen gel layer. Quantitative analyses of EC network formation revealed that the length, number, and depth of the EC networks were significantly enhanced in a 3D model with ECs and EPCs compared to an EC monoculture. In addition, conditioned medium (CM) from the 3D model with ECs and EPCs promoted network formation compared to CM from an EC monoculture. We also confirmed that EPCs secreted vascular endothelial growth factor (VEGF). However, networks cultured with the CM were shallow and did not penetrate the collagen gel in great depth. Therefore, we conclude that EPCs contribute to 3D network formation at least through indirect incorporation by generating a local VEGF gradient. These results suggest that the location of EPCs is important for controlling directional 3D network formation in the field of tissue engineering. Citation: Abe Y, Ozaki Y, Kasuya J, Yamamoto K, Ando J, et al. (2013) Endothelial Progenitor Cells Promote Directional Three-Dimensional Endothelial Network Formation by Secreting Vascular Endothelial Growth Factor. PLoS ONE 8(12): e82085. doi:10.1371/journal.pone.0082085 Editor: Andreas Zirlik, University Heart Center Freiburg, Germany Received February 4, 2013; Accepted October 30, 2013; Published December 3, 2013 Copyright: © 2013 Abe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: The authors have no support or funding to report. Competing interests: The authors have declared that no competing interests exist. * E-mail: tanishita@aoni.waseda.jp

[1]  I. Geudens,et al.  Coordinating cell behaviour during blood vessel formation , 2011, Development.

[2]  H. Gerhardt,et al.  Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting , 2010, Nature Cell Biology.

[3]  J. Holtz,et al.  Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting. , 2010, International journal of cardiology.

[4]  I. Baumgartner,et al.  Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell Transplantation , 2009, PloS one.

[5]  Ali Khademhosseini,et al.  Progress in tissue engineering. , 2009, Scientific American.

[6]  J. Ando,et al.  Contribution of rat endothelial progenitor cells on three-dimensional network formation in vitro. , 2009, Tissue engineering. Part A.

[7]  Milica Radisic,et al.  Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. , 2008, Acta biomaterialia.

[8]  I. Morita,et al.  A comparison of the tube forming potentials of early and late endothelial progenitor cells. , 2008, Experimental cell research.

[9]  Arash Momeni,et al.  In vitro angiogenesis properties of endothelial progenitor cells: a promising tool for vascularization of ex vivo engineered tissues. , 2007, Tissue engineering.

[10]  T. Asahara [Endothelial progenitor cells for vascular medicine]. , 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[11]  Oju Jeon,et al.  Combined Sustained Delivery of Basic Fibroblast Growth Factor and Administration of Granulocyte Colony-Stimulating Factor: Synergistic Effect on Angiogenesis in Mouse Ischemic Limbs , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[12]  C. Heeschen,et al.  Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. , 2005, Journal of molecular and cellular cardiology.

[13]  Federica Boschetti,et al.  Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Ouchi,et al.  VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signaling , 2005, Journal of Cell Science.

[15]  T. Asahara,et al.  Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via “Imported” Nitric Oxide Synthase Activity , 2005, Circulation.

[16]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[17]  H. Masuda,et al.  Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. , 2003, Cardiovascular research.

[18]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[19]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial☆ , 2002 .

[20]  Holger Gerhardt,et al.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.

[21]  I. Zagon,et al.  Differential effects of vascular growth factors on arterial and venous angiogenesis. , 2002, Journal of vascular surgery.

[22]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[23]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[24]  T. Murohara,et al.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.

[25]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Pearlman,et al.  Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. , 2000, The Journal of pharmacology and experimental therapeutics.

[27]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[28]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[29]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[30]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[31]  Masayuki Yamato,et al.  Current Status of Regenerative Medicine from the Viewpoint of Tissue Engineering , 2009 .

[32]  Yan-hong Huang,et al.  Purification and growth of endothelial progenitor cells from murine bone marrow mononuclear cells , 2008, Journal of cellular biochemistry.